Product Description
Dr. August Wolff & KG Arzneimittel is developing WO-3308 as a treatment for Pruritus. (Sourced from: https://classic.clinicaltrials.gov/ct2/show/NCT03477058)
Mechanisms of Action: Unknown
Novel Mechanism: No
Modality: Unknown
Route of Administration: Topical
FDA Designation: *
Approval Status: Not Approved
Approved Countries: None
Approved Indications: None
Known Adverse Events: None
Company: Dr. August Wolff GmbH & Co. KG Arzneimittel
Company Location:
Company Founding Year: None
Additional Commercial Interests: None
Clinical Description
Countries in Clinic:
Active Clinical Trial Count:
Recent & Upcoming Milestones
Highest Development Phases
Trial ID |
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
Latest Trial Update Date |
Data Updated |
|---|---|---|---|---|---|---|---|---|
NCT03477058 |
LPC-17/2016 | N/A |
Completed |
Pruritus |
2017-02-06 |
2019-03-22 |
Treatments |
Recent News Events
Date |
Type |
Title |
|---|